www.oradesibiu.ro/2026/10/23/un-mare-producator-de

Heineken warns that the rise of weight-loss drugs in the UK could impact alcohol consumption habits, urging pubs to adapt or risk losing customers. The company highlights that medications like GLP-1 can reduce alcohol cravings, leading to smaller purchases. Heineken suggests promoting smaller beer servings and low-alcohol options. The beverage industry faces declining sales as health-conscious consumers drink less. Heineken is monitoring changes in consumer behavior related to these medications, noting that users still drink but in smaller quantities. Other producers have varied responses, with Diageo optimistic about managing sales impacts, while Carlsberg sees no clear link yet.